Skip to main content
Press Release

Former New Jersey Resident Admits Conspiring to Distribute Fentanyl Analogue

For Immediate Release
U.S. Attorney's Office, District of New Jersey

NEWARK, N.J. – A former New Jersey resident today admitted conspiring to distribute a fentanyl analogue, Acting U.S. Attorney Rachael A. Honig announced.

Darryl Hinkson, 46, formerly of Jersey City, New Jersey, pleaded guilty by videoconference before U.S. District Judge Claire C. Cecchi to an information charging him with conspiracy to distribute and possess with the intent to distribute 100 grams or more of a fentanyl analogue.

According to documents filed in this case and statements made in court:

From Sept. 11, 2018, to Oct. 18, 2018, Hinkson conspired with others to distribute pills that contained a fentanyl analogue, an illegal controlled substance. On Sept. 11, 2018, Hinkson met with an individual (Individual-1) and sold Individual-1 approximately 20 pills of purported “Percocet” and 20 pills of purported “Xanax” in exchange for U.S. currency. On Sept. 25, 2018, Hinkson again met with Individual-1 and sold Individual-1 550 pills of purported “Percocet” and approximately 300 pills of purported “Xanax” in exchange for U.S. currency. The pills were not, in fact, Percocet or Xanax, but instead contained a fentanyl analogue.

The count of conspiracy to distribute and possess with intent to distribute fentanyl analogue carries a maximum penalty of life in prison and a fine of $10 million. Sentencing is scheduled for Dec. 9, 2021.

Acting U.S. Attorney Honig credited special agents and task force officers of the Drug Enforcement Administration, under the direction of Special Agent in Charge Susan A. Gibson in Newark, with the investigation leading to today’s guilty plea.

The government is represented by Assistant U.S. Attorney Adam Baker of the Opioid Abuse Prevention and Enforcement Unit.

Updated July 20, 2021

Drug Trafficking
Press Release Number: 21-318